Antiviral agents against HBV infection
US9938236B2 · kind B2 · utility
0Cited by
3References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 27, 2013 |
| Grant date | Apr 10, 2018 |
| Priority date | — |
| Expiry date | Dec 27, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds of formula (I) and methods of use thereof. In certain embodiments, the compounds of the invention are useful as nucleocapsid assembly inhibitors. In other embodiments, the compounds of the invention are useful as pregenomic RNA encapsidation inhibitors of Hepatitis B virus (HBV). In yet other embodiments, the compounds of the invention are useful for the treatment of viral infection, including HBV and related viral infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.